Papers

Multiomics research explores new therapies for inhibiting gastric cancer

  • Li XIE , 1 ,
  • Wenyan SHI 1 ,
  • Xinlin LI 1 ,
  • Juanjuan XIONG 1 ,
  • Jingjing LIU 1 ,
  • Hongliang YAO 1 ,
  • Chengyuan ZHOU 1 ,
  • Wei HUANG , 2, *
Expand
  • 1. College of Animal Science and Food Engineering, Jinling Institute of Technology, Nanjing 210038, China
  • 2. Affiliated Hospital of Nanjing University of Chinese Medicine/Jiangsu Provincial Hospital of Traditional Chinese Medicine, Nanjing 222000, China

Received date: 2023-11-16

  Online published: 2025-06-26

Copyright

All rights reserved. Unauthorized reproduction is prohibited.

Cite this article

Li XIE , Wenyan SHI , Xinlin LI , Juanjuan XIONG , Jingjing LIU , Hongliang YAO , Chengyuan ZHOU , Wei HUANG . Multiomics research explores new therapies for inhibiting gastric cancer[J]. Science & Technology Review, 2025 , 43(11) : 97 -106 . DOI: 10.3981/j.issn.1000-7857.2023.11.01686

1
Rawla P, Barsouk A. Epidemiology of gastric cancer: Global trends, risk factors and prevention[J]. Przeglad Gastroentero-logiczny, 2019, 14(1): 26- 38.

2
Qi Y F, Sun J N, Ren L F, et al. Intestinal microbiota is altered in patients with gastric cancer from Shanxi Province, China[J]. Digestive Diseases and Sciences, 2019, 64(5): 1193- 1203.

DOI

3
Bai Z G, Zhang Z T, Ye Y J, et al. Sodium butyrate induces differentiation of gastric cancer cells to intestinal cells via the PTEN/phosphoinositide 3-kinase pathway[J]. Cell Biology International, 2010, 34(12): 1141- 1145.

DOI

4
Nielsen-Preiss S M, Silva S R, Gillette J M. Role of PTEN and Akt in the regulation of growth and apoptosis in human osteoblastic cells[J]. Journal of Cellular Biochemistry, 2003, 90(5): 964- 975.

DOI

5
Li X, Leu S, Cheong A, et al. Akt2, phosphatidylinositol 3-kinase, and PTEN are in lipid rafts of intestinal cells: Role in absorption and differentiation[J]. Gastroenterology, 2004, 126(1): 122- 135.

DOI

6
Wei J, Wu J, Xu W, et al. Salvianolic acid B inhibits glycolysis in oral squamous cell carcinoma via targeting PI3K/AKT/HIF-1α signaling pathway[J]. Cell Death & Disease, 2018, 9(6): 599.

7
Myzak M C, Dashwood R H. Histone deacetylases as targets for dietary cancer preventive agents: Lessons learned with butyrate, diallyl disulfide, and sulforaphane[J]. Current Drug Targets, 2006, 7(4): 443- 452.

DOI

8
Miranti E H, Stolzenberg-Solomon R, Weinstein S J, et al. Low vitamin B12 increases risk of gastric cancer: A prospective study of one-carbon metabolism nutrients and risk of upper gastrointestinal tract cancer[J]. International Journal of Cancer, 2017, 141(6): 1120- 1129.

DOI

9
Mamede A C, Tavares S D, Abrantes A M, et al. The role of vitamins in cancer: A review[J]. Nutrition and Cancer, 2011, 63(4): 479- 494.

DOI

10
Montiel-Ruiz R M, González-Trujano M E, Déciga-Campos M. Synergistic interactions between the antinociceptive effect of Rhodiola rosea extract and B vitamins in the mouse formalin test[J]. Phytomedicine, 2013, 20(14): 1280- 1287.

DOI

11
Hassan I, Chibber S, Naseem I. Vitamin B2:A promising adjuvant in cisplatin based chemoradiotherapy by cellular redox management[J]. Food and Chemical Toxicology, 2013, 59: 715- 723.

DOI

12
Chen N, Yin S T, Song X H, et al. Vitamin B2 sensitizes cancer cells to vitamin-C-induced cell death via modulation of Akt and bad phosphorylation[J]. Journal of Agricultural and Food Chemistry, 2015, 63(30): 6739- 6748.

DOI

13
Chou T C. Drug combination studies and their synergy quantification using the Chou-Talalay method[J]. Cancer Research, 2010, 70(2): 440- 446.

DOI

14
Zhang X Q, Xie L, Zheng M, et al. Aurora kinase inhibitors attached to iron oxide nanoparticles enhances inhibition of the growth of liver cancer cells[J]. Journal of Nanoparticle Research, 2015, 17(6): 247.

DOI

15
Zhang N, Fu J N, Chou T C. Synergistic combination of microtubule targeting anticancer fludelone with cytoprotective panaxytriol derived from Panax ginseng against MX-1 cells in vitro: Experimental design and data analysis using the combination index method[J]. American Journal of Cancer Research, 2016, 6(1): 97- 104.

16
Mirzaei R, Afaghi A, Babakhani S, et al. Role of microbiota-derived short-chain fatty acids in cancer development and prevention[J]. Biomedicine & Pharmacotherapy, 2021, 139: 111619.

17
Pan L N, Lu J, Huang B Q. HDAC inhibitors: A potential new category of anti-tumor agents[J]. Cellular & Molecular Immunology, 2007, 4(5): 337- 343.

18
Lu R, Wang X, Sun D F, et al. Folic acid and sodium butyrate prevent tumorigenesis in a mouse model of colorectal cancer[J]. Epigenetics, 2008, 3(6): 330- 335.

DOI

19
Pan L N, Matloob A F, Du J, et al. Vitamin D stimulates apoptosis in gastric cancer cells in synergy with trichostatin A/sodium butyrate-induced and 5-aza-2'-deoxycytidine-induced PTEN upregulation[J]. The FEBS Journal, 2010, 277(4): 989- 999.

DOI

20
Ogura R, Katsuki T, Daoud A H, et al. Anti-oxidative effects of vitamin B2-butyrate on the cardiac mitochondrial disorders induced by adriamycin[J]. Journal of Nutritional Science and Vitaminology, 1982, 28(4): 329- 334.

DOI

21
Imran M, Saeed F, Gilani S A, et al. Fisetin: An anticancer perspective[J]. Food Science & Nutrition, 2021, 9(1): 3- 16.

22
Pan Z H, Luo Y C, Xia Y, et al. Cinobufagin induces cell cycle arrest at the S phase and promotes apoptosis in nasopharyngeal carcinoma cells[J]. Biomedicine & Pharmacotherapy, 2020, 122: 109763.

23
Lea M A, Ibeh C, Shah N, et al. Induction of differentiation of colon cancer cells by combined inhibition of kinases and histone deacetylase[J]. Anticancer Research, 2007, 27(2): 741- 748.

Outlines

/